27 May 2015
NovaMedica, a Russian pharmaceutical company, participated in the White Nights-2015 International Ophthalmology Congress and hosted a satellite symposium “NovaMedica: New Ophta Horizons”. The symposium was started by Boris Malyugin, Deputy General Director for Science at MNTK “Eye Microsurgery” named after Federov S.N., and presented the first publication of in vitro research results on potency of netilmicin and reference drug products.
13 April 2015
April 6-10, 2015, Moscow hosted the 22nd Russian National Congress “People and Medicines”. NovaMedica have actively participated in R&D part of its program and organized a symposium “Venture investments in Research and Development” chaired by Mikhail Getman, Vice President for Pharmaceutical Operations at NovaMedica.
20 March 2015
NovaMedica participated in the annual conference “The 14th All-Russian Ophthalmologist School 2015” near Moscow. The event welcomed more than 200 medical specialist from all over Russia. The opinion leaders’s reports and presentations covered various issues of therapeutical and surgical ophtalmology.
12 March 2015
“The production strategies based only on import substitutule won’t last for long,” noted Sergey Beloborodov, the Ecexutive Director of NovaMedica at the round-table discussion “Attracting investments to pharmaceutical industry” held during the InvestRus International Conference in Moscow March 11, 2015.
22 January 2015
Russian pharmaceutical company NovaMedica and Omega Pharma, a Belgium-based pan-European pharmaceutical company specializing in the development and sale of over-the-counter (OTC) health and personal care products, have signed a partnership agreement granting NovaMedica exclusive rights to promote, distribute and sell a line of OTC gastrointestinal products under the BenegastTM umbrella brand in Russia.
25 September 2014
NovaMedica LLC, a Russian pharmaceutical company, and Horus Pharma SL, a French company dedicated to the development of innovative products treating ophthalmic diseases, have signed a partnership agreement that grants NovaMedica exclusive rights to commercialize a portfolio of products in Russia and the Commonwealth of Independent States (CIS).
18 June 2014
“We have worked our way up from the concept of RusnanoMedInvest portfolio building to first sales of NovaMedica pharmaceutical company within two years’ time. This pace of development is considered fast in the pharmaceutical industry”, - Vladimir Gurdus, CEO, RMI Partners, Management Company of RusnanoMedInvest (RMI) and NovaMedica said during his speech at 20th Russian Pharmaceutical Forum in St. Petersburg.
23 May 2014
In general terms, engagement of private companies in the healthcare system on a competitive basis shall result in the price optimization and improvement of the quality of medical services provided and pharmaceuticals delivered to patients, Leonid Melamed, Chairman of the Board, Team Drive; Member of the Board of Directors, RusnanoMedInvest and NovaMedica said on Friday at St. Petersburg SPIEF2014.
22 May 2014
Russian pharmaceutical company “NovaMedica” won “Best Employer” prize as part of the National business award “Captains of the Russian Business”. The award winners are selected by the professional jury following the results of market experts’ opinion and companies’ activities survey over the past year.
25 March 2014
Leading Italian developer of innovative eye care solutions S.I.F.I. S.p.A. (SIFI) and Russian pharmaceutical company NovaMedica have entered into an exclusive commercial agreement for NovaMedica to market eight products developed and licensed by SIFI for the treatment of a wide range of ophthalmic pathologies in Russia and the CIS.
18 January 2019
18 January 2019
17 January 2019
17 January 2019